We performed intracardiac electrophysiologic studies of the effects of
vasoactive intestinal peptide (VIP, 0.125 mu g/kg/min) on sinus and a
trioventricular (AV) nodal function, intracardiac conduction, and myoc
ardial refractoriness in two groups of neonatal dogs (aged 6-16 d). Gr
oup I consisted of eight neonates in whom VIP was administered after b
ilateral vagotomy and beta-blockade with propranolol. Group II consist
ed of five neonates studied after vagotomy and propranolol, plus total
chemical sympathectomy (6-hydroxydopamine). In both groups, VIP resul
ted in a significant shortening of sinus cycle length. AV nodal conduc
tion time, measured as the AH interval (the time from the onset of the
atrial electogram to the onset of the His bundle electrogram in the H
is electrode catheter) during atrial pacing, also shortened after VIP.
His-Purkinje conduction time and atrial effective refractory periods
were unchanged by VIP. In other experiments, the direct chronotropic e
ffect of VIP was evaluated in five isolated neonatal canine hearts usi
ng a modified Langendorff technique. In these hearts, the spontaneous
cycle length decreased from 403 +/- 88 to 293 +/- 69 ms, or -28 +/- 4%
(mean +/- SD), after exposure to 0.1-0.5 nmol of VIP (p < 0.001). In
nine other newborns (aged 4-16 days), the effect of selective (alpha(1
)- and alpha(2)-adrenergic receptor blockade on the positive chronotro
pic effect of VIP was evaluated. The effect of VIP on sinus cycle leng
th was not altered by the alpha(1)-adrenergic receptor blocker prazosi
n or by the (alpha(2)-adrenergic receptor blocker yohimbine. These dat
a indicate that, in the neonatal dog, VIP shortens sinus cycle length
and AV nodal conduction time but has no effect on infra-nodal conducti
on or myocardial refractoriness. We find no evidence that VIP's chrono
tropic effect is modified by alpha-adrenergic receptor blockade. VIP m
ay play a role in the neural modulation of heart rate and AV nodal con
duction in the neonate.